: Pericardiocentesis is a valuable technique for the diagnosis and treatment of patients with pericardial effusion and cardiac tamponade, although it may be associated with potentially serious complications. Through the years, many different imaging approaches have been described to reduce the complication rate of the procedure. This systematic review provides a focused overview of the different techniques developed in recent years to reduce the procedural complications and to increase the related success rate.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2459/JCM.0000000000000649 | DOI Listing |
Tunis Med
October 2024
University of Tunis El Manar, Faculty of Medicine of Tunis, 1007, Aziza Othmana Hospital, Department of pediatric hematology, 1008, Tunis, Tunisia.
Curr Cardiol Rep
December 2024
Feinberg School of Medicine, Northwestern Memorial Hospital, 675 N St Clair St Ste 19-100 Galter Pavilion, Chicago, IL, 60611-5969, USA.
Purpose Of Review: To discuss the evolution in the approach to pericardial effusions and drainage from a historical perspective, the present state, and pathways for future innovative therapies.
Recent Findings: Incorporation of advanced imaging tools has dramatically improved the safety profile of pericardial interventions. Outcome data allow for refined approaches to management of pericardial disease in special populations, such as pulmonary arterial hypertension.
Tuberculous pericarditis (TBP) is one of the most important causes of pericarditis in developing countries in which tuberculosis remains a public health problem. We report the case of a 20-year-old immunocompetent woman who presented with hypotension and tachycardia echocardiography showed a massive pericardial effusion and signs of tamponade. The patient underwent an urgent pericardiocentesis; 700 ccs of serosanguinous pericardial fluid was drained.
View Article and Find Full Text PDFWorld J Clin Cases
September 2021
Department of Gastroenterology, The 2 Affiliated Hospital of Harbin Medical University, Harbin 150086, Heilongjiang Province, China.
Background: Infliximab (IFX) is an anti-tumor necrosis factor alpha (TNF-α) agent that is widely used for the management of a variety of autoimmune and inflammatory diseases, including Crohn's disease (CD). As a result of its increasing administration, new complications have emerged. Hemorrhagic pericardial effusion, secondary to IFX therapy, is a rare but life-threatening complication.
View Article and Find Full Text PDFJ Cardiol Cases
March 2021
Cardiology Department, University Hospital of Badajoz, Badajoz, Spain.
Herein is described the case of a 39-year-old female agronomist who was admitted to hospital after a syncopal episode. She had had fever, abdominal pain, nausea, and vomiting for the previous month. The patient showed signs of hypoperfusion, so a trans-thoracic echocardiography was done, demonstrating the presence of a cardiac tamponade.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!